Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Kotzia (Cambridge, United Kingdom), F. Kiparissi (London, United Kingdom), H. Spencer (London, United Kingdom). First description of De Novo Inflammatory Bowel Disease (IBD) in two adolescent patients after lung transplant (LTX). 2736

Member's Comments

No comment yet.

Related content which might interest you: Impact of Inflammatory bowel disease in bronchiectasis (IBD-BR) data from the EMBARC registry Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD) Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch Source: International Congress 2014 – ILDs 2 Year: 2014 Benefit of steroid-free treatment compared to standard therapy (ST) in pulmonary sarcoidosis Source: International Congress 2014 – ILDs 5 Year: 2014 Venous thromboembolic disease (VTD) associated with inflammatory bowel disease (IBD): RIETE´s experience Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 TB status in a dynamic cohort of patients with Inflammatory Bowel Disease receiving immunosuppression treatment, with up to 8 years of follow-up. Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I Year: 2019 Associations of gut microbiota and Chronic Obstructive Pulmonary Disease Assessment Test (CAT) score in chemotherapy treated lung cancer patients with COPD Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD) Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT) Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco Year: 2020 Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009 Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Unclassifiable Interstitial Lung Disease (ILD). Why? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Sporadic and TSC-related lymphangioleiomyomatosis (LAM): The experience of Ospedale San Paolo of Milan (preliminary data) Source: International Congress 2014 – ILDs 3 Year: 2014 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021